Owlet, the pioneer of smart infant monitoring, announces De Novo clearance from the U.S. Food and Drug Administration (“FDA”) of Dream Sock, the first and only over-the-counter medical pulse oximetry solution for infants.
Altera Digital Health, a global health IT leader, today announced that Resilience Healthcare, a health system serving the Chicago metropolitan region, has signed an approximately seven-year contract to leverage the company’s Paragon® electronic health record (EHR) platform, designed for community hospitals.
Welldoc®, a digital health leader revolutionizing chronic care, today announced data demonstrating that the use of a digital health application in a virtual program for individuals with type 2 diabetes was associated with significant improvements in weight loss, as well as favorable trends in post-meal blood glucose and systolic blood pressure.
Azra AI, a healthtech leader using artificial intelligence (AI) and workflow automation to accelerate the identification and treatment of cancer, is excited to announce it is a member of CancerX, a public-private partnership aimed at unleashing the power of innovation to fight cancer in the United States.
Black Opal Ventures (BOV), founded by managing directors Dr. Tara Bishop and venture capitalist Eileen Tanghal, today announced their inaugural health-tech fund which has raised $58M to date.
Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, announced today new data indicating Baxter’s Sharesource remote patient management (RPM) digital platform, when used with an automated peritoneal dialysis (PD) system, is associated with a 77% reduction in risk of PD technique failure.
ARLINGTON, Va.--(BUSINESS WIRE)--ReferWell, the leading digital health company in patient care scheduling, and CareJourney, the market leader in provider cost and quality data, have announced the release of ReferWell’s Perfect Match℠ solution powered b...
Five-year study evaluates entire Quantum Health client base; third-party validated actuarial analysis indicates market-leading 3.3 to ROI in year one and 5.3 to 1 ROI (4.8 ROI net of reductions to administrative fees) after year three of deploying Qu...
Verana Health® (Verana), a digital health company helping to revolutionize patient care and clinical research by unlocking the potential of real-world data, and the Foundation Fighting Blindness – the world’s leading organization committed to finding treatments and cures for blinding retinal diseases—announce a partnership focused on providing the life sciences community with deeper and broader data to optimize and expedite clinical trials.
Aktivolabs, a digital health science company on a mission to prevent chronic diseases globally, announced today it has joined the American Heart Association Center for Health Technology & Innovation (the Center) Innovators’ Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.